Systematic Reviews· 2026Q1
Remote behavioural activation therapy for depressive symptoms among older adults in resource-limited settings: a protocol for a systematic review and meta-analysis
- 0citations
- Q1SCImago
- 2026year
Short summary
This protocol outlines a systematic review and meta-analysis to evaluate the efficacy of remote behavioural activation therapy (RBAT) for depressive symptoms in older adults (60+) in resource-limited settings.
AI-generated from the title and abstract; the full text is not read.
Key points
- Systematic review and meta-analysis protocol to evaluate RBAT efficacy for depressive symptoms in older adults (60+) in resource-limited settings.
- Searches will cover major databases (PubMed, Web of Science, etc.) up to July 1, 2025, focusing on RCTs.
- Primary outcome is depressive symptom severity measured by validated scales; meta-analysis will use random-effects models.
- Risk of bias and certainty of evidence will be assessed using established frameworks (Cochrane RoB 2, GRADE).
- Subgroup and meta-regression analyses will explore heterogeneity and identify optimal intervention characteristics.
AI-generated from the title and abstract; the full text is not read.
Abstract
Depressive symptoms represent a severe mental health burden among older adults, particularly in resource-limited settings with scarce mental healthcare resources. Although behavioural activation is an established evidence-based intervention, the efficacy of remote behavioural activation therapy (RBAT), its optimal intervention characteristics, and overall evidence certainty remain systematically unevaluated in this vulnerable population. This systematic review and meta-analysis aims to synthesise evidence from randomised controlled trials (RCTs) to evaluate the efficacy of RBAT. Eligible studies will include RCTs evaluating RBAT among adults aged 60 years or above experiencing depressive symptoms in resource-limited settings. Studies will be identified through systematic searches of PubMed, Web of Science, Embase, CINAHL, PsycINFO and the Cochrane Library from inception to 1 July 2025. The primary outcome is depressive symptom severity measured using validated continuous depression scales. Standardised mean differences with 95% confidence intervals will be pooled using random-effects models. Risk of bias will be assessed using the Cochrane Risk of Bias tool version 2, and the certainty of evidence will be evaluated using the Grading of Recommendations, Assessment, Development and Evaluation framework. Subgroup analyses and exploratory meta-regression analyses will be performed to examine heterogeneity. This systematic review will be conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. In summary, this review will provide a rigorous synthesis of RBAT efficacy for depressive symptoms among older adults living in resource-limited settings. By quantifying the certainty of evidence and identifying key characteristics associated with treatment variations, the findings will clarify the current evidence base, guide future research, and inform scalable digital mental health strategies for these underserved populations. PROSPERO CRD42025627772.
The authors' abstract, as published at the source. Systematic Reviews, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Applied Psychology
Applied PsychologyPsychology